Table 2.
Characteristics of responders vs overcorrectors and non-responders at 24 h. (responders = achieving sodium rise between 5 and 10 mmol/L at 24 h, overcorrectors= achieving sodium rise >10 mmol/L at 24 h, and non-responder= achieving sodium rise <5 mmol/L at 24 h).
| Responders (n = 44) (A) | Overcorrectors (n = 48) (B) | P value (A and B) | Non-responders n =15 (C) | P value (A and C) | |
|---|---|---|---|---|---|
| Mean age ± s.d. (years) | 72.23 ± 15.24 | 60.17 ± 13.47 | 0.237 | 70.02 ± 16.64 | 0.637 |
| Weight ± s.d. (kg) | 71.28 ± 15.64 | 67.23 ± 17.72 | 0.179 | 67.34 ± 15.36 | 0.414 |
| Height ± s.d. (m2) | 1.66 ± 0.08 | 1.68 ± 0.10 | 0.090 | 1.66 ± 0.10 | 0.415 |
| BMI ± s.d. (kg/m2) | 26.17 ± 5.62 | 23.79 ± 5.58 | 0.741 | 24.45 ± 6.03 | 0.336 |
| Sex | Females= 26 Males= 18 |
Females= 24 Males= 24 |
0.382 | Females= 9 Males= 6 |
0.951 |
| Mean Na+ at baseline ± s.d. (mmol/L) | 113.7 ± 5.82 | 112.31 ± 6.37 | 0.381 | 116.27 ± 5.63 | 0.143 |
| Mean number of Na+ readings in first 24 h after infusion ± s.d. | 3.68 ± 1.57 | 3.94 ± 1.77 | 0.918 | 3.53 ± 2.56 | 0.790 |
| Aetiology | |||||
| SIAD | 14 (31.8%) | 12 (25%) | 0.206 | 4 (26.7%) | 0.384 |
| SIAD and drug-induced | 16 (36.4%) | 13 (27.1%) | 7 (46.7%) | ||
| Hypovolemia | 3 (6.8%) | 5 (10.4%) | 2 (13.3%) | ||
| Hypovolemia and drug-induced | 5 (11.4%) | 6 (12.5%) | 0 (0%) | ||
| Drug-induced only | 2 (4.5%) | 6 (12.5%) | 0 (0%) | ||
| Hypervolemia | 4 (9.1%) | 1 (2.1%) | 1 (6.7%) | ||
| Others | 0 (0%) | 2 (4.2%) | 0 (0%) | ||
| Unknown | 0 (0%) | 3 (6.3%) | 1 (6.7%) | ||
| Length of stay (days) | 18.4 ± 15.4 | 11.4 ± 9.1 | 0.022 | 21.53 ± 19.95 | 0.527 |
| Symptoms | |||||
| Acute confusion (%) | 22 (50%) | 24 (50%) | 1.000 | 6 (40%) | 0.203 |
| Seizures (%) | 7 (15.9%) | 18 (37.5%) | 0.020 | 1 (6.7%) | 0.161 |
| Reduced consciousness (%) | 11 (25%) | 13 (27.1%) | 0.820 | 0 (0%) | 0.028 |
| Vomiting (%) | 11 (25%) | 10 (20.8%) | 0.634 | 5 (33%) | 0.168 |
| Biochemical severity of hyponatraemia only (%) | 10 (22.7%) | 8 (16.7%) | 0.464 | 2 (13.3%) | 0.180 |
| Location | |||||
| Ward (%) | 29 (65.9%) | 28 (58.4%) | 0.426 | 14 (93.3%) | 0.136 |
| High dependency or intensive care units (%) | 4 (9.1%) | 10 (20.8%) | 0 (0%) | ||
| A&E (%) | 11 (25%) | 10 (20.8%) | 1 (6.7%) | ||
| Number of boluses | |||||
| 1 (%) | 12 (27.3%) | 21 (43.8%) | 0.461 | 5 (33.3%) | 0.518 |
| 2 (%) | 20 (45.5%) | 18 (37.5%) | 5 (33.3%) | ||
| 3 or more (%) | 12 (31.9%) | 9 (18.8%) | 5 (33.3%) | ||
| History of alcohol excess (%) | 10 (22.7%) | 18 (37.5%) | 0.124 | 3 (20%) | 0.826 |
| Underweight (%) | 2 (4.5%) | 5 (10.4%) | 0.289 | 2 (13.3%) | 0.242 |
| Overcorrection treatment | |||||
| Use of desmopressin (%) | 0 (0%) | 5 (10.4%) | 0.028 | 0 (0%) | N/A |
| Use of dextrose (%) | 5 (11.4%) | 15 (31.3%) | 0.021 | 0 (0%) | 0.172 |
| Specialist endocrine opinion (%) | 34 (77.3%) | 45 (93.8%) | 0.023 | 11 (73.3%) | 0.757 |
| Death during same admission | 2 (4.5%) | 1 (2.1%) | 0.507 | 3 (20%) | 0.063 |
| 12-month mortality | 8 (18.2%) | 8 (16.7%) | 0.848 | 3 (20%) | 0.876 |
A&E, accident and emergency department; SIAD, syndrome of inappropriate antidiuresis; TSH, thyroid-stimulating hormone.
Bold indicates statistical significance, P < 0.05.
This work is licensed under a